FindTrial
Sign In

To test the irritation potential of Amrutanjan Pain balm

EVALUATION OF IRRITATION POTENTIAL OF PAIN BALMS (A & B) FROM AMRUTANJAN R&D DEPT. THROUGH DERMATOLOGICAL EVALUATION BY SINGLE OCCLUSIVE PATCH TEST ON HEALTHY ADULT HUMAN VOLUNTEERS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045339
Enrollment
24
Registered
2022-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Amrutanjan pain balms: Each gm contains, Karpura 10% Yavani satva 1% Pudinah 10% Gandhapura patra taila 12% Sarala 2% Tailaparna taila 9% Bhutrna 5% Darusita taila 1% Pudinah (Oil) 2% L

Sponsors

Amrutanjan Health Care Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy subjects with healthy skin on the studied anatomic unit (free of eczema, wounds & any other inflammatory scar) 2. Age group of 18 to 55 years, 12 male and 12 female subjects. 3. Compliance with the study procedures involved.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Subjects with any other skin disorders. 3. Use of any other topical agents for any skin related conditions (at the site of application of patch) during the past 30 days.

Design outcomes

Primary

MeasureTime frame
the severity mean scores for Erythema/dryness/wrinkles will be calculated and mean score of oedema will be calculated separatelyTimepoint: Day 1, 2 and 8—

Secondary

MeasureTime frame
Combined mean score calculationTimepoint: Day 8—

Countries

India

Contacts

Public ContactSAKTHIBALAN M

Ki3

saheerose@gmail.com09843591097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026